Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Js Innomed Holdings Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by a distinct examiner in a distinct art unit. The company's current patent office activity is concentrated in this pending case, reflecting a focused intellectual property effort. This action is the only matter currently requiring attention from the company's legal team. The focus on Biotechnology & Pharmaceuticals indicates a specialized technical field for their medical innovations.
Jackson J Hernandez is the busiest examiner for the portfolio, with 1 pending office action. This action represents the total pending workload for the company, meaning the prosecution status is currently dependent on the review by Jackson J Hernandez. Practitioners should analyze the examiner's history closely, as Jackson J Hernandez is the sole examiner currently evaluating the company's technology. The progress of this case will determine the company's immediate patent achievements.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725113 | HETEROCYCLIC COMPOUNDS AS SHP2 INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | HERNANDEZ, JACKSON J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725113 | HETEROCYCLIC COMPOUNDS AS SHP2 INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | HERNANDEZ, JACKSON J | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725113 | HETEROCYCLIC COMPOUNDS AS SHP2 INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | HERNANDEZ, JACKSON J | 1627 | §101§103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJs Innomed Holdings Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jackson J Hernandez has the most, with 1 of Js Innomed Holdings Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
